Dianthus Therapeutics | MGTA - DEBITO

Prezzo Delle Azioni
84.13
Cambio Giornaliero
-3.03 -3.48%
Mensile
5.89%
Annuale
286.80%
Q2 Previsione
85.52




DEBITO Cambiamento Data
Akebia Therapeutics USD 46.51M 7.82M 2025-03
Alaunos Therapeutics USD 10.99M 5.78M 2023-03
Avita Medical AUD 46.05M 1.46M 2025-12
Celltrion KRW 171.09B 2.05T 2025-06
Cspc Pharmaceutical CNY 495M 12.33M 2025-06
Deva Holding AS TRY 5.3B 871.93M 2023-09
Dianthus Therapeutics USD 1.28M 45K 2025-09
Divis Laboratories Ltd INR 40M 40M 2025-03
IQVIA Holdings USD 15.72B 767M 2025-12
Kangmei Pharma CNY 131.64M 90.18M 2025-06
Knight Therapeutics CAD 77.91M 28.33M 2025-12
Laboratorios Farma EUR 129.3M 14.89M 2025-06
Malin Corporation EUR 100K 0 2023-12
Medical Developments International AUD 1.99M 152K 2025-06
Moderna USD 734M 7M 2025-09
Neuren Pharmaceuticals AUD 0 0 2024-12
Organon & Co USD 8.83B 68M 2025-09
Ovoca Bio EUR 0 0 2021-06
Pharma Mar EUR 49.42M 1.98M 2025-12
Qiagen NV USD 1.81B 314.82M 2025-12
Revvity USD 3.37B 5.86M 2025-09
Sartorius EUR 4.28B 372.9M 2025-12
Sino Biopharmaceutical CNY 9.71B 33.98M 2024-12
Tectonic Therapeutic USD 876K 115K 2024-12
Tilray USD 640.95M 35.17M 2022-06
Viatris USD 14.41B 25.6M 2025-12
Xeris Pharmaceuticals USD 257.65M 431K 2025-09
Zz Pientze Pharmaceu CNY 1.07B 52.69M 2025-06